Cure My Disease

Don't miss your cure!

 Log in / Sign up

A phone game takes on menopause brain fog

NCT ID NCT07800793

Symptom relief Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests whether a mobile game designed for menopausal women can reduce brain fog and improve psychological well-being. Women aged 45 to 55 who have gone through menopause will be randomly assigned to either play the game for 15 minutes a day, 5 days a week, for 6 weeks, or to receive routine care only. Researchers will compare changes in brain fog and well-being scores between the two groups to see if the game helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A mobile game designed for menopausal women, with cognitive exercises targeting attention, memory, and processing speed.
What this could lead to
If it works, this could offer a simple, drug-free way for menopausal women to sharpen their thinking and feel better day to day.
What could go wrong
The trial is small and early, so results may not hold up. The game's benefits, if any, may be modest and not last beyond the 6-week study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 82 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Women aged 45-55 years Able to read and write in Turkish Able to use a smartphone (Android or iOS) Amenorrhea for at least 12 months Willing to participate and provide written informed consent Exclusion Criteria: Diagnosis of serious neurological disorders such as dementia, Alzheimer's disease, epilepsy, or multiple sclerosis Diagnosis of severe psychiatric disorders such as major depression, bipolar disorder, or schizophrenia Regular use of medications that may significantly affect cognitive function, including antiepileptics, antiparkinsonian drugs, antipsychotics, or antidepressants Participation in cognitive training, memory training, or a similar digital intervention within the last 6 months Visual, auditory, or motor impairments that would prevent the use of the mobile application Participants scoring within the lowest 25% quartile (Q1) on the Brain Fog Scale

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain fog are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Mental Fatigue Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain fog Menopause Psychological well-being

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • İstanbul Medipol University Mega Hospital

    Istanbul, Mrs, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.